About Healionics
Healionics is a company based in Seattle (United States) founded in 2007. It operates as a HealthTech. Healionics has raised $28.54 million across 20 funding rounds from investors including HHS, Keiretsu Forum and Keiretsu Capital. Healionics offers products and services including STARgraft Vascular Graft. Healionics operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Healionics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.54 M (USD)
in 20 rounds
-
Latest Funding Round
$1.96 M (USD), Series C
Dec 16, 2025
-
Investors
HHS
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Healionics
Healionics offers a comprehensive portfolio of products and services, including STARgraft Vascular Graft.
A vascular graft designed for dialysis access.
People of Healionics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Healionics
Healionics has successfully raised a total of $28.54M across 20 strategic funding rounds. The most recent funding activity was a Series C round of $1.96 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Healionics
Healionics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Keiretsu Forum and Keiretsu Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by Keiretsu Capital into multiple sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Healionics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Healionics
Investment portfolio details for Healionics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Healionics
Detailed financials for Healionics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Healionics Comparisons
Peer comparison for Healionics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Healionics
Healionics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
Detailed competitors of Healionics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Healionics
Complete news archive for Healionics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Healionics
Healionics was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Healionics is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Healionics is a funded company, having raised a total of $28.54M across 20 funding rounds to date.
Solutions for safer and more reliable bloodstream access for dialysis are provided by Healionics. Focus is placed on patients with kidney failure, aiming to improve health, longevity, and quality of life while reducing treatment costs. The STARgraft vascular graft, leveraging the STAR biomaterial scaffold, is designed to resist occlusion and infection. Collaborations with key organizations in Seattle, such as the University of Washington and Northwest Kidney Centers, are maintained to advance dialysis technology and clinical innovation in the healthcare sector.
Healionics's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Healionics offers STARgraft Vascular Graft.
Healionics has 8 investors. Key investors include HHS, Keiretsu Forum, Keiretsu Capital, Cascadia Venture Forum, and Bellingham Angel Group.